A Comparison of Ligase Chain Reaction to

Similar documents
Lowering the cut off value of an automated chlamydia enzyme immunoassay and confirmation

JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 1998, p Vol. 36, No. 11. Copyright 1998, American Society for Microbiology. All Rights Reserved.

Mailed, Home-Obtained Urine Specimens: a Reliable Screening Approach for Detecting Asymptomatic Chlamydia trachomatis Infections

Technical Bulletin No. 98b

Received 23 September 1997/Returned for modification 16 January 1998/Accepted 19 February 1998

Diagnosis of Chlamydia trachomatis Infections in Asymptomatic Men and Women by PCR Assay

Evaluation of Bias in Diagnostic-Test Sensitivity and Specificity Estimates Computed by Discrepant Analysis

Comparison of Three Nucleic Acid Amplification Tests for Detection of Chlamydia trachomatis in Urine Specimens

Masatoshi Tanaka, Hiroshi Nakayama, Kazuyuki Sagiyama, Masashi Haraoka, Hiroshi Yoshida, Toshikatsu Hagiwara, Kohei Akazawa, Seiji Naito

Evaluation of the Vidas Chlamydia Test To Detect and Verify Chlamydia trachomatis in Urogenital Specimens

Performance of a Commercial Polymerase Chain Reaction Test for Endocervical Chlamydia trachomatis Infection in a University Hospital Population

Diagnosis by AMPLICOR PCR of Chlamydia trachomatis Infection in Urine Samples from Women and Men Attending Sexually Transmitted Disease Clinics

Evaluation of Nucleic Acid Amplification Tests as Reference Tests for Chlamydia trachomatis Infections in Asymptomatic Men

/01/$ DOI: /JCM Copyright 2001, American Society for Microbiology. All Rights Reserved.

Aminopeptidase Assay

JOURNAL OF CLINICAL MICROBIOLOGY, July 1999, p Vol. 37, No. 7. Copyright 1999, American Society for Microbiology. All Rights Reserved.

A School-based Chlamydia Control Program Using DNA Amplification Technology

CHLAMYDIA/GC AMPLIFIED RNA ASSAY

Correct samples for diagnostic tests in sexually transmitted diseases: which sample for which test? 1

Received 13 November 1997/Returned for modification 27 January 1998/Accepted 16 February 1998

Chlamydia trachomatis (CHLa)Test Kit

Evaluation of CDC-Recommended Approaches for Confirmatory Testing of Positive Neisseria gonorrhoeae Nucleic Acid Amplification Test Results

Infection with Chlamydia trachomatis is

ABSTRACT. KEY WORDS antibiotics; prophylaxis; hysterectomy

Received 26 November 2003/Returned for modification 6 January 2004/Accepted 6 April 2004

Effect of Endocervical Specimen Adequacy for Detection of ACCEPTED. Wyoming Public Health Laboratory, 517 Hathaway Bldg., 2300 Capitol Ave.

Original article. Office of Disease Prevention and Control, region 10 Chiang Mai, 2 Sanpatong Hospital, 3

Received 12 July 2004/Returned for modification 29 August 2004/Accepted 18 October 2004

for Treatment of Chlamydial Infection in Pregnancy

The value of urine samples from men with nongonococcal

Immunodiagnosis of Sexually Transmitted Disease

2014 CDC GUIDELINES CHLAMYDIA & GONORRHEA DIAGNOSTICS. Barbara Van Der Pol, PhD, MPH University of Alabama at Birmingham

New CT/GC Tests. CDC National Infertility Prevention Project Laboratory Update Region II May 13-14, 2009

Received 8 September 2005/Returned for modification 12 October 2005/Accepted 9 November 2005

Case Report Diagnostic Challenges of Tuberculous Lymphadenitis Using Polymerase Chain Reaction Analysis: A Case Study

For in vitro Veterinary Diagnostics only. Kylt Rotavirus A. Real-Time RT-PCR Detection.

Effect of Blind Passage and Multiple Sampling on Recovery of Chlamydia trachomatis from Urogenital Specimens

Genital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management. William M. Geisler M.D., M.P.H. University of Alabama at Birmingham

Chlamydia Rapid Screen Test (RAP-2858) RUO in the USA. Revised 28 Jul 2006

Evaluation of the microparticle enzyme immunoassay Abbott IMx Select Chlamydia and

RealLine Mycoplasma genitalium Str-Format

Head-to-Head Evaluation of Five Chlamydia Tests Relative to a Quality-Assured Culture Standard

Assessment of Chlamydia trachomatis infection in asymptomatic male partners of infertile couples

Controls for Chlamydia trachomatis and Neisseria gonorrhoea

Joyee A. George, Thyagarajan S. Panchatcharam*, Rajendran Paramasivam, Sowmya Balasubramanian, Venkatesan Chakrapani 1 and Ganapathy Murugan 1

The accuracy and efficacy of screening tests for Chlamydia trachomatis: a systematic review

Performance of the Abbott RealTime CT/NG for Detection of

Evaluation of the Abbott RealTime CT/NG Assay in Comparison to the Roche Cobas Amplicor CT/NG Assay

Browning M R, Corden S, Mitchell B, Westmoreland D. Setting The setting was a clinical laboratory. The economic study was conducted in the UK.

Duration of Persistence of Gonococcal DNA Detected by Ligase Chain Reaction in Men and Women following Recommended Therapy for Uncomplicated Gonorrhea

Murex Chlamydia Verification Kit

Controls for Chlamydia trachomatis and Neisseria gonorrhoea

Human Immunodeficiency Virus-Positive Women

87491 Chlamydia trachomatis, amplified probe technique Neisseria gonorrhoeae, amplified probe technique. Virology (Performed on Mpls campus)

Received 16 December 2005/Returned for modification 6 February 2006/Accepted 6 May 2006

Be sure! Your Power for Health. PelvoCheck CT/NG Your test kit for Chlamydia trachomatis screening and Neisseria gonorrhoeae infections

T he organisms Chlamydia trachomatis and Neisseria gonorrhoeae

/01/$ DOI: /JCM Copyright 2001, American Society for Microbiology. All Rights Reserved.

Performance of the Abbott RealTime CT/NG for the Detection of Chlamydia. trachomatis and Neisseria gonorrhoeae

Received 13 August 2001/Returned for modification 22 November 2001/Accepted 24 January 2002

VQA HIV DNA Control SOP Version 5.0 HIV DNA Testing 13 March 2012

LABORATORY VALIDATION OF XPERT CT/NG AND TV TESTING AS PERFORMED BY NURSES AT THREE PRIMARY HEALTHCARE FACILITIES IN SOUTH AFRICA

VQA Control SOP Version 4.0 Roche Amplicor HIV-1 DNA Test, v August 2007

Chlamydia Trachomatis IgG ELISA Kit

Instructions for Use. RealStar Influenza Screen & Type RT-PCR Kit /2017 EN

endocervical, urethral, rectal, and pharyngeal

Research Article Challenges in Assessing Outcomes among Infants of Pregnant HIV-Positive Women Receiving ART in Uganda

Guidelines for the Laboratory Detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Treponema pallidum Testing

Quarterly laboratory and pathology update from Legacy Laboratory Services in collaboration with Cascade Pathology

Office and Laboratory Management of Genital Specimens

A randomized trial of azithromycin versus amoxicillin for the treatment of Chlamydia trachomatis in pregnancy

Received 21 March 2005/Returned for modification 25 April 2005/Accepted 9 June 2005

Evaluation of the Digene Hybrid Capture II Assay with the Rapid Capture System for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae

MOLECULAR DIAGNOSTICS OF INFECTIOUS DISEASES: STABILITY OF SPECIMENS DURING PREANALYTICS

ISPUB.COM. Chlamydia in female reproductive tract. D Pandey, J Shetty, M Pai, Pratapkumar INTRODUCTION BURDEN OF SUFFERING MICROBIOLOGICAL ASPECT

Prevalence of human papillomavirus and Chlamydia trachomatis infection in paired urine and cervical smear samples of Palestinian young women.

Instructions for Use. RealStar Influenza S&T RT-PCR Kit /2017 EN

Chlamydia trachomatis Load at Matched Anatomic Sites: Implications for Screening Strategies

About HPV. Human papillomavirus (HPV) is a group of viruses that are extremely common worldwide. Theree are more than 100 types of HPV, of which at

A Randomized, Double-Blind, Placebo-Controlled Trial of 5-Fluorouracil for the Treatment of Cervicovaginal Human Papillomavirus

M.T. Tam, 1. M. Yungbluth, 2 and T. Myles 3 1Department of Obstetrics and Gynecology, St. Joseph Hospital, Chicago, IL

Laboratory Procedure Manual

Performance of the Abbott Real Time CT/NG assay in urines and cervicovaginal samples from Senegal

ENG MYCO WELL D- ONE REV. 1.UN 29/09/2016 REF. MS01283 REF. MS01321 (COMPLETE KIT)

New diagnostic tests for sexually transmitted infections. Jens Van Praet 30/11/2018

Molecular Diagnosis of Sexually-transmitted Chlamydia trachomatis in the United States

Laboratory Methods for Detection of Chlamydia trachomatis: Survey of Laboratories in Washington State

WHO Prequalification of Diagnostics Programme PUBLIC REPORT. Product: Abbott RealTime HIV-1 (m2000sp) Number: PQDx

Research Article Comparison of Colour Duplex Ultrasound with Computed Tomography to Measure the Maximum Abdominal Aortic Aneurysmal Diameter

LOCUS MEDICUS SA, 2012

Treatment of Uncomplicated Chlamydia trachomatis Cervicitis

UPDATE MOLECULAR DIAGNOSTICS IN SEXUAL HEALTH. Dr Arlo Upton Clinical Microbiologist Labtests Auckland

NIH Public Access Author Manuscript Sex Transm Infect. Author manuscript; available in PMC 2013 June 04.

October Courier Service on Holidays There will be no courier service Thursday, Dec. 24th, 2011.

Received 11 April 2003/Returned for modification 10 June 2003/Accepted 30 June 2003

Reliable, cost-effective CT/GC testing For labs with low to medium throughput needs. The BD ProbeTec ET System

William W. Hale III, 1 Quinten A. W. Raaijmakers, 1 Anne van Hoof, 2 and Wim H. J. Meeus 1,3. 1. Introduction

HPV-DNA Test Kit in Cervical Scrapes or

Sample page. Laboratory Services. Coding and Payment Guide

Transcription:

Infectious Diseases in Obstetrics and Gynecology 6:57-60 (I 998) (C) 1998 Wiley-Liss, Inc. A Comparison of Ligase Chain Reaction to Polymerase Chain Reaction in the Detection of C.hlamydia trachomatis Endocervical Infections J.D. Davis, 1. P.K. Riley, 1 C.W. Peters, 2 and K.H. Rand 3 1Department of Obstetrics and Gynecology, University of Florida College of Medicine, Gainesville, FL edepartment of Emergency Medicine, University of Florida College ofmedicine, Gainesville, FL -Department of Pataology, Immunology and Laboratory Medicine, Medicine, Gainesville, FL ABSTRACT University of Florida College of Objective: To compare the reliability of ligase chain reaction (LCR) to polymerase chain reaction (PCR) in detecting Chlamydia trachomatis endocervical infections. Methods: We conducted a prospective study of 486 patients at risk for chlamydial infection of the endocervix. We obtained two endocervical specimens from each patient and used LCR and PCR to detect C. trachomatis. Discrepant results between the two techniques were resolved by repeat testing and by testing for the major outer membrane protein (MOMP) gene, if necessary. We determined the sensitivity, specificity, positive predictive value, and negative predictive value for each test, using concordant results or MOMP gene results as the "gold standard." Results: Of the 486 patients, 42 (8.6%) had evidence of C. trachomatis infection after resolution of discrepant results. Of the 42 true positive specimens, 41 were positive by initial LCR and 38 were positive by initial PCR. Of the 444 true negative specimens, none had a positive initial LCR result, while 2 had a positive initial PCR test. Therefore, compared to the gold standard, LCR had a sensitivity of 97.6% and specificity of 100%, while PCR had a sensitivity of 90% and a specificity of 99.5%. The positive and negative predictive values of LCR were 100% and 99.8%, respectively. PCR had a positive predictive value of 95% and a negative predictive value of 99.1%. The difference in sensitivity of LCR versus PCR was not statistically significant (P.125). Conclusion: LCR and PCR perform equally well in detecting C. trachomatis endocervical infections. Infect. Dis. Obstet. Gynecol. 6:57-60, 1998. (C) 1998 Wiley-Liss, Inc. KEY WORDS chlamydial infection; endocervix; DNA amplification techniques ulture in mammalian cell lines has been considered the "gold standard" for diagnosing Calamydia tracaomatis; however, this method is labor intensive, time consuming, and expensive. Non-culture methods, including direct fluorescent antibody (DFA) testing and enzyme immunoassays, have been employed but lack the sensitivity and specificity of tissue culture. More recently, DNA amplification techniques, including the polymerase chain reaction (PCR)-based Amplicor (7. tracaomatis Test (Roche Molecular Systems, Branchburg, NJ) and the ligase chain reaction (LCR)-based LCx Probe System (Abbott Laboratories, Chicago, IL), have been used to diagnose Grant sponsor: Abbott Laboratories, Chicago, Illinois. Presented at the 45th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists, Las Vegas, Nevada, April 26-30, 1997. *Correspondence to Dr. John D. Davis, Director, Division of Gynecology, Department of Obstetrics and Gynecology, University of Florida College of Medicine, PO Box 100294, Room M-302E, Gainesville, FL 32610-0294. E-Mail: davisjd@obgyn.med.ufl.edu Received 6 February 1998 Research Article Accepted 5 May 1998

DETECTION OF C. TRACHOMATIS ENDOCERVICAL INFECTIONS urogenital chlamydial infections with improved sensitivity, e,- To our knowledge, two studies have been published comparing LCR to PCR in the detection of chlamydial infections of the urogenital tract. In the first study, de Barbeyrac et al. 4 found LCR to be more sensitive than PCR in the diagnosis of endocervical and urethral chlamydial infections; the difference in sensitivity was not statistically significant. In the second study, Pasternack et al. s likewise could find no statistically significant difference between LCR and PCR; however, they believed the manual PCR was superior to LCR, because only the manual PCR correctly identified all chlamydia-positive patients. The purpose of our study was to determine if either LCR or PCR was superior in detecting C. trachomatis endocervical infections. SUBJECTS AND METHODS Between April and July 4, 1996, we obtained two endocervical specimens from 486 women seen at the University of Florida Shands Hospital who were at risk for chlamydial infection. Specimens were obtained from new obstetric patients; gynecologic patients with pelvic pain, mucopurulent cervical discharge, or other signs or symptoms possibly attributable to chlamydia infection; and all reproductive-aged women seen in the Emergency Department regardless of their chief reason for seeking treatment. We conducted this study under a protocol approved by the Institutional Review Board. To obtain specimens, examiners first removed any cervical discharge with a large cotton swab. They then sampled the endocervical canal sequentially with two Dacron swabs, rotating each swab for 15-30 seconds to ensure adequate sampling. They placed and left the swab for LCR testing into the LCR transport media. The examiners vigorously swirled the swab for PCR testing in the PCR transport media, expressed excess fluid, and removed the swab in accordance with the manufacturer s instructions. The specimens were kept at room temperature and transported to the laboratory within 12 hours of collection and kept refrigerated for not more than 48 hours prior to testing. Laboratory personnel were blinded to the LCR and PCR results for each matched pair until the final result for each method was determined. After testing, specimens were held frozen at-70c in case further studies needed to be performed. The LCx Probe System uses four primers with specificity for the C. trachomatis cryptic plasmid. Laboratory technicians performed this test after direct training from the manufacturer using methods previously described. 3 Briefly, the specimen was first heat denatured at 97C for 15 minutes and 100 pl was added to amplification vials containing all reagents for amplification. The amplification was carried out in a thermocycler for 40 cycles, and the entire run was transferred to the analyzer which adds all reagents for the detection of the amplified product. The amplification and detection steps were performed in a physically separate area from the setup of new specimens. All test runs included appropriate calibrators, together with positive and negative controls provided by the manufacturer. PCR was performed according to the instructions from the manufacturer as previously described, e In this procedure, ml of Specimen Diluent was added to the patient specimen and 50 pl of the mixture was added to the PCR tube containing the PCR Master Mix. After 30 cycles of thermal amplification in the presence of biotin labeled primers also directed towards the C. trachomatis cryptic plasmid, the reaction mixture was transferred to a microtiter plate coated with a DNA capture probe. The amplified product was then detected with the addition of avidin-horseradish peroxidase in an ELISA format. Thermocycling was carried out with Uracil-N-glycosylase to prevent carryover contamination. As specified by the manufacturer, one positive control and one negative control tested in triplicate were included with each test run. All specimens testing within the equivocal range for either method were repeated twice. None of the PCR results were equivocal. Only two of the LCR results were in the equivocal range. On repeat testing, one specimen was positive and one was negative. Any specimen that tested positive by one method but not by the other was tested again by both methods, and all such discrepant specimens were sent to the Roche and Abbott laboratories under code for repeat testing and resolution using primers for the major outer membrane protein (MOMP) gene, if necessary. We calculated the sensitivity, specificity, and positive and negative pre- 58 INFECTIOUS DISEASES IN OBSTETRICS AND GYNECOLOGY

DETECTION OF C. TRACHOMATIS ENDOCERVICAL INFECTIONS TABLE I. Resolution of discrepant results at Abbott and Roche Laboratories Case Initial Initial Resolved LCR Resolved PCR number LCR result PCR result result (Abbott) result (Roche) + + 2 + + + 3 + + + 4 + + + 5 + + Not done* 6 / 7 + Final diagnosis *The remaining PCR specimen was accidentally discarded. dictive values for both tests using concordant resuits on initial or repeat testing or MOMP gene results for persistently discordant tests as the gold standard. We then performed an exact form of the McNemar test to determine if the difference in sensitivities of the two tests was significant. RESULTS Of the 486 patients, 442 tested negative initially by both tests, while 37 patients were positive initially by both LCR and PCR. Seven patients had discordant initial LCR and PCR results (Table 1). Four patients were positive by LCR and negative by PCR (cases 1-4). Repeat testing in our laboratory confirmed these results. Upon duplicate.testing on undiluted specimens at the outside laboratories, all four PCR specimens tested positive; the LCR resuits remained unchanged. Three patients were negative by LCR and positive by PCR (cases 5-7). Repeat testing in our laboratory confirmed the initial results. Two of these patients (numbers 6 and 7) had both negative LCR and PCR tests on undiluted specimens at the outside laboratories (initial false-positive PCR tests). The remaining patient (number 5) tested positive by LCR when the test was repeated on an undiluted specimen (initial false negative LCR). Testing for the MOMP gene was not required to resolve discrepancies on any specimens. Of the 486 patients, 42 (8.6%) had evidence of C. trachomatis infection after resolution of discrepant results. Of the 42 true positive specimens, 41 tested positive by initial LCR and 38 tested positive by initial PCR. Of the 444 specimens negative by both methods on initial or repeat testing, none had a positive initial LCR result, while two had a positive initial PCR result. Therefore, using the resolved results as the gold standard, LCR had a sensitivity and specificity of 97.6% and 100%, respectively, while PCR had a sensitivity of 90% and a specificity of 99.5%. The positive and negative predictive values of LCR were 100% and 99.8%, respectively. PCR had a positive predictive value of 95% and a negative predictive value of 99.1%. The difference in sensitivity of LCR versus PCR was not statistically significant (P.125). DISCUSSION LCR and PCR techniques both utilize DNA amplification technology, and both methods are more sensitive in diagnosing C. trachomatis endocervicitis than older methods, such as culture, DFA, or ELISA. In this head to head comparison using endocervical specimens, the original LCR result proved to be correct in six of the seven discordant pairs while the original PCR result was correct in only one pair. The difference in performance of LCR versus PCR was not statistically significant. In a study of over 2,000 patients, Schachter et al. compared LCR to cell culture for the diagnosis of C. trachomatis endocervicitis using endocervical specimens and found the sensitivity of LCR was 94% versus 65% for culture. These authors concluded LCR was a highly sensitive method for detecting C. trachomatis endocervicitis and called for a direct comparison between LCR and PCR to determine which test was better. The first such study was published by de Barbeyrac et al., 4 who studied 134 women from a low-risk population and 84 women and 62 men from a high-risk population. In the female group, the authors compared the performance of LCR, PCR, and tissue culture using endocervical specimens. A specimen was considered truly positive if the culture was positive, if the LCR and PCR were both positive, or if the MOMP gene was positive when the LCR and PCR results INFECTIOUS DISEASES IN OBSTETRICS AND GYNECOLOGY 59

DETECTION OF C. TRACHOMATIS ENDOCER VICAL INFECTIONS were discordant. A specimen was truly negative if the culture and either the LCR or PCR were negative. The sensitivity of LCR was 95.2% versus 80.9% for both PCR and culture; the specificity of both LCR and PCR was 99.6%. The difference in sensitivity of LCR versus PCR was not statistically significant. The authors concluded LCR was a good alternative to PCR in the detection of chlamydial infections. Pasternack et al. s recently compared the results of LCR and PCR on first void urine specimens to tissue culture on endocervical specimens in the detection of C. trachomatis infections in 442 female patients. Positive culture, positive LCR and PCR results, and a positive MOMP gene test when the LCR and PCR results were discordant were considered truly positive. In their study, PCR had a sensitivity of 100% and specificity of 99.7%, while the sensitivity and specificity of LCR was 94% and 100%, respectively. Again, the difference in sensitivity between the two tests was not statistically significant. However, the authors believed the manual PCR was better than LCR because the manual PCR detected all chlamydia-positive patients. As with the above reports, our study did not demonstrate a statistically significant difference in the performance of LCR versus PCR. However, after resolution of the discordant specimens, the original LCR result proved to be correct in six of the seven discordant pairs while the initial PCR result was correct only once. In our study, there was a single false-negative LCR and four false-negative PCR results. These false-negative results may have been caused by ligase or polymerase inhibitors, a problem to which both DNA amplification tests are susceptible. 1,6 We cannot confirm this since we did not perform any specific tests to determine if inhibiting factors were present. Whether LCR is possibly less sensitive to inhibitors must await further study. A limitation of our study is that we did not obtain specimens for confirmatory tissue culture. Therefore, it is possible that some of our concordant pairs were both falsely positive or both falsely negative and our calculated sensitivities and specificitie are overestimates. This would be a serious drawback to our study if our purpose was to determine the exact sensitivity and specificity of LCR and PCR. However, our purpose was to directly compare the relative performance of two tests which have already been shown to be more sensitive and nearly as specific as tissue culture. DNA amplification tests are reported to be greater than 90% sensitive and greater than 99% specific, while tissue culture is typically 75-85% sensitive and considered 100% specific. 3-7 While our calculated sensitivities and specificities may be overestimates of the true values for both LCR and PCR, the number and nature of the discordant pairs are unaffected. Therefore, even though we did not obtain confirmatory tissue cultures, the relative performance of LCR versus PCR, and the results of our study, are unchanged. REFERENCES 1. Schachter J, Stamm WE, Quinn TC, Andrews WW, Burczak JD, Lee HH: Ligase chain reaction to detect Chlamydia trachomatis infection of the cervix. J Clin Microbiol 32:2540-2543, 1994. 2. Loeffelholtz MJ, Lewinski CA, Silver SR, Purohit AP, Herman SA, Buonagurio DA, Dragon EA: Detection of Chlamydia trachomatis in endocervical specimens by polymerase chain reaction. J Clin Microbiol 30:2847-2851, 1992. 3. Dille BJ, Butzen CC, Birkenmeyer LG: Amplification of Chlamydia trachomatis DNA by ligase chain reaction. J Clin Microbiol 31:729-731, 1993. 4. de Barbeyrac B, Rodriguez P, Dutilh B, Le Roux P, Bebear C: Detection of Chlamydia trachomatis by ligase chain reaction compared with polymerase chain reaction and cell culture in urogenital specimens. Genitourin Med 71:382-386, 1995. 5. Pasternack R, Vuorinen P, Pitkajarvi T, Koskela M, Miettinen A: Comparison of manual Amplicor PCR, Cobas Amplicor PCR, and LCx assays for detection of Chlamydia trachomatis infection in women by using urine specimens. J Clin Microbiol 35:402-405, 1997. 6. Verkooyen RP, Luijendijk A, Huisman WM, Goessens WHF, Kluytmans JAJW, van Rijsoort-Vos JH, Verbrugh HA: Detection of PCR inhibitors in cervical specimens by using the AMPLICOR Chlamydia trachomatis assay. J Clin Microbiol 34:3072-3074, 1996. 60 INFECTIOUS DISEASES IN OBSTETRICS AND GYNECOLOGY

MEDIATORS of INFLAMMATION The Scientific World Journal Gastroenterology Research and Practice Diabetes Research International Endocrinology Immunology Research Disease Markers Submit your manuscripts at BioMed Research International PPAR Research Obesity Ophthalmology Evidence-Based Complementary and Alternative Medicine Stem Cells International Oncology Parkinson s Disease Computational and Mathematical Methods in Medicine AIDS Behavioural Neurology Research and Treatment Oxidative Medicine and Cellular Longevity